Healthcare Stocks

100-300% return in a year! Should you buy these 2 AIM stocks?

 100-300% return in a year! Should you buy these 2 AIM stocks?

Highlights ValiRx inked a contract with a renowned London university to test new technology for the treatment of breast cancer. As per the terms of the contract, it will conduct preclinical tests on the drug candidate for nine months to validate...

Read More...
What Led to A Surge in Astrazeneca’s Product Sales In 2020?

What Led to A Surge in Astrazeneca’s Product Sales In 2020?

Summary The pharma company announced that its Q4 2020 sales had jumped by 12 per cent to just over $7 billion. The company said it could take about six to nine months to make new vaccines protecting against new strains of the Covid-19 virus. T...

Read More...
Dechra Pharma wins licence to sell Tri-Solfen in Australia, NZ 

Dechra Pharma wins licence to sell Tri-Solfen in Australia, NZ 

Summary Dechra Pharmaceuticals announced it had secured the right to sell animal pain management product Tri-Solfen in Australia and New Zealand markets. The pharma company can now market the cattle drug worldwide The Londo...

Read More...
Covid-19: Van-Tan Assures Usage of Astrazeneca Vaccine Safe for Brits

Covid-19: Van-Tan Assures Usage of Astrazeneca Vaccine Safe for Brits

Summary At a press conference at the Downing Street on Monday, Professor Jonathan Van-Tan reassured Brits that they were safe after South Africa suspended AstraZeneca’s vaccine rollout. A recent study has highlighted that AstraZeneca-Oxfo...

Read More...
Active Biotech and Famar Health Care sign a manufacturing deal 

Active Biotech and Famar Health Care sign a manufacturing deal 

Summary Both the healthcare sector companies have signed a contract on Thursday, 4 February. Under the agreement, Famar Health will be providing Active Biotech with clinical trial material.  &nb...

Read More...
Astrazeneca’s Covid-19 Vaccine Efficient for Elders, Says UK Regulators

Astrazeneca’s Covid-19 Vaccine Efficient for Elders, Says UK Regulators

Summary The British-Swedish pharma major has come up with extra trial data which shows that vaccine is effective in the elderly group Some of the European nations have been doubting whether the vaccine is effective on elderly age group or not ...

Read More...
Sensyne Health Unveils AI Algorithm for Real-Time Hospital Management 

Sensyne Health Unveils AI Algorithm for Real-Time Hospital Management 

Summary Sensyne Health unveiled its first operational artificial intelligence algorithm SYNE-OPS-1 The SYNE-OPS-1 provides real-time operational decision-making support to healthcare managers.  The company's CEO Lord Drayson plans to...

Read More...
Jazz Pharmaceuticals acquires GW Pharmaceuticals for £5.3 billion

Jazz Pharmaceuticals acquires GW Pharmaceuticals for £5.3 billion

Summary GW Pharmaceuticals has announced that Ireland’s Jazz Pharmaceuticals will be buying it out for £3 billion in a cash and stock deal.  The deal is likely to close by the second quarter of this year. GW’s drug ...

Read More...
McKinsey agrees to $573mn multi-state opioid settlement 

McKinsey agrees to $573mn multi-state opioid settlement 

Summary McKinsey has agreed to a multi-state settlement claim of at least US $573 million for its sales and marketing advice to Oxycontin maker Purdue Pharma. McKinsey’s settlement claims are with 43 states, the District of Columbia and t...

Read More...
AstraZeneca Oxford vaccine could lead to fall in coronavirus spread, claims study

AstraZeneca Oxford vaccine could lead to fall in coronavirus spread, claims study

Summary A scientific study suggests that a single dose of the AstraZeneca Oxford vaccine lowers the Covid-19 virus transmission by two-third. A single shot offers 76 per cent immunity against the virus for up to a period of three months. A...

Read More...
Moderna Inc (NASDAQ: MRNA) initiates additional filling of vials containing Covid-19 vaccine 

Moderna Inc (NASDAQ: MRNA) initiates additional filling of vials containing Covid-19 vaccine 

Summary The pharma company has proposed increasing of filling vials by up to five additional doses. The US FDA had initially purchased 200 million doses of Moderna vaccine, following which it ordered additional 100 million jabs. ...

Read More...